Implemented a third-party allocation of new shares.

Tokyo, Sep. 9, 2017


Noile-immune Biotech announces Implementing financing on September 8, 2017 by a third party allocation of new shares to Takeda Pharmaceutical Company Limited (TSE: 4502). With this funding Noile-immune will not only strengthen the foundation of our management base, but also accelerate our R&D.